Skip to content
Medical InsightsKoreaMedical Insights Korea

Prostate

I've been told the prostate tablet can make me dizzy. Is that dangerous?

The risk is real, it is concentrated on one specific day, and that is what makes it manageable rather than alarming.

By

Reporter

Published
Reading time
4 minutes

Answer

The dizziness is a drop in blood pressure on standing, and it does raise the risk of falling — but almost entirely at the start. In a Korean national cohort of 53,303 matched pairs of men aged 60 to 75, alpha-antagonists prescribed for benign prostatic hyperplasia carried an odds ratio for falls of 1.80 (95% CI 1.62 to 2.00), and of the 968 falls recorded in the treated group 455 — 47 percent — happened on the first day of medication, with a further excess in summer (OR 1.23); the same class showed no association with heart failure in a separate Korean cohort of 22,540 men (HR 1.14, 95% CI 0.87 to 1.49).

Key takeaways

  • Alpha-blockers relax smooth muscle, which opens the bladder outlet and also lowers blood pressure on standing.
  • In 53,303 matched pairs of Korean men aged 60 to 75, the odds ratio for a fall was 1.80 (95% CI 1.62 to 2.00).
  • 455 of the 968 falls in the treated group — 47 percent — occurred on the first day of medication.
  • Falls were more likely in summer among treated men only (OR 1.23, 95% CI 1.03 to 1.47).
  • Heat causes vasodilation and fluid loss, both of which deepen a postural drop in blood pressure.
  • In a separate Korean cohort of 22,540 men, alpha-blockers showed no association with heart failure (HR 1.14, 95% CI 0.87 to 1.49).
  • The study authors recommend that education on orthostatic hypotension accompany the prescription.

The dizziness has a name — orthostatic hypotension — and a mechanism that follows directly from what the drug is for. Alpha-blockers relax smooth muscle. That is how they open the outlet of the bladder, and blood vessels are made of smooth muscle too, so the same action lowers blood pressure when you stand up.

How much the risk actually rises

A Korean study screened 4,202,739 men aged 60 to 75 in national claims data and compared 53,303 men taking an alpha-antagonist against the same number matched on other characteristics. The odds of a fall were 1.80 times higher in the treated group.

455 of 968

falls in the treated group that happened on the first day of medication — 47 percent of the totalSeo JH et al., World Journal of Urology, 2022

That second figure is the one worth carrying out of the room. Nearly half of the falls landed on a single, entirely predictable day. The circulation adapts to the drug over the following days, which is why first-dose effects are described for this class and steady-state ones are not.

What to do about it

None of this is a reason to decline the medication. It is a reason to know which day matters, and the evidence that the risk is concentrated there is what turns a vague warning into something you can act on.

The worry that did not show up

Because these drugs affect blood pressure, a reasonable question is whether they strain the heart over time. A separate Korean national cohort followed 22,540 men newly diagnosed with benign prostatic hyperplasia between 2008 and 2018 and found no association with heart failure: incidence was 516.8 per 100,000 person-years among users against 553.4 among non-users, with an adjusted hazard ratio of 1.14 and a confidence interval running from 0.87 to 1.49.

Read together the two studies give a more precise answer than "it affects your circulation". The effect that appears in Korean data is postural and immediate. The chronic cardiac one that people ask about does not appear at all.

Tell the doctor what else you take

The first-dose drop is larger in men already on blood pressure medication, and larger again in anyone on a drug for erectile dysfunction, which works through a related mechanism. Neither combination is forbidden and both are worth naming before the prescription is written rather than after the fall.

Sources

  1. 1

    Seo JH, Han JS, Lee Y, Myong JP, Ha US

    Fall risk related to subtype-specific alpha-antagonists for benign prostatic hyperplasia: a nationwide Korean population-based cohort study

    World Journal of Urology 2022;40(12):3043-3048

    doi:10.1007/s00345-022-04195-w · PMID:36315286

    https://doi.org/10.1007/s00345-022-04195-w
  2. 2

    Jeong JY, Kim MK, Shin JY

    The association between alphablockers in the treatment of benign prostatic hyperplasia and heart failure: a nationwide population-based cohort study in South Korea

    International Journal of Clinical Pharmacology and Therapeutics 2025;63(1):21-29

    doi:10.5414/cp204600 · PMID:39565077

    https://doi.org/10.5414/cp204600